Digi.Bio is bridging the digital and biological world with AI and automation.
Digi.Bio has raised $343K in total funding. The most recent round was Convertible Note. The last funding was announced in October 2021.
Digi.Bio's investors include SOSV, Innovatiefonds Noord-Holland, MassChallenge Switzerland, SOSV HAX, ACE Incubator.
Digi.Bio is headquartered in Amsterdam, The Netherlands.
Digi.Bio is bridging the digital and biological world with AI and automation.
Digi.Bio is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Digi.Bio — Funding & Investors." VCBacked, October 1, 2021, https://www.vcbacked.co/company/digibio. Accessed September 13, 2026.
VCBacked. (2021). Digi.Bio — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/digibio
{{cite web |title=Digi.Bio — Funding & Investors |url=https://www.vcbacked.co/company/digibio |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated